Bio
Dr. Ansuman Satpathy, M.D., Ph.D., is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design, co-director of the Parker Institute for Cancer Immunotherapy, and co-director of the Immunotherapy Program in the Stanford Cancer Institute. Ansu's research combines expertise in immunology, high-throughput genomics, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. He is a co-founder of Immunai, Cartography Biosciences, Santa Ana Bio, and Prox Biosciences, and a venture partner at Wing Venture Capital.
Ansu holds a BS in molecular biology and BA in philosophy from the University of Illinois, an MD and PhD in immunology from Washington University in St.Louis, and completed his clinical residency and postdoctoral training in genetics at Stanford University.
